Objectives: To investigate whether the major fungal multidrug efflux systems (MESs) affect the efficiency of methylene blue (MB)-mediated antimicrobial photodynamic inactivation (APDI) in pathogenic fungi and test specific inhibitors of these efflux systems to potentiate APDI.
Introduction
Infections caused by fungi can be serious, especially in immunocompromised and debilitated patients (HIV infection, transplantation, corticosteroid therapy and lymphoma). 1 The incidence of invasive mycoses has increased significantly over the last 3 decades and now represents an exponentially growing threat for human health due to a combination of difficult diagnosis and a shortage of effective antifungal drugs. Thus, systemic fungal infections result in high attributable mortality. Candida albicans is the most common pathogenic yeast species, representing about 60% of all yeasts isolated in clinical samples. Azole antifungals are commonly used for fungal infections; however, recurrence of clinical signs is a common observation. 2, 3 High-level, clinically significant azole resistance usually involves overexpression of plasma membrane multidrug efflux systems (MESs) belonging to the ATP-binding cassette (ABC) or the major facilitator superfamily (MFS) classes of transporters. 4 -7 Phylogenetic analysis of the ABC family has provided a new understanding of this important class of efflux pumps. Several approaches have been proposed to tackle efflux-mediated antifungal drug resistance, including (i) the use of alternative antifungal drugs that are not efflux pump substrates (such as the echinocandins); (ii) targeting efflux pump transcriptional regulators and fungal stress response pathways; (iii) blockade of energy supply; and (iv) direct pharmacological inhibition of efflux pumps.
Photodynamic therapy (PDT) combines a non-toxic photoactivatable dye or photosensitizer (PS) with harmless visible light of the correct wavelength to excite the dye to its reactive triplet state, which will then generate reactive oxygen species such as singlet oxygen and hydroxyl radicals that are toxic to cells. 8 -10 # The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com J Antimicrob Chemother 2011; 66: 1525 -1532 doi:10.1093/jac/dkr160 Advance Access publication 26 April 2011 PDT, discovered more than 100 years ago, has a killing effect on microorganisms, 11 and has been successfully employed in clinics as a treatment for cancer 12 and age-related macular degeneration. 13 The exponentially increasing threat of microbial multidrug resistance has highlighted antimicrobial photodynamic inactivation (APDI) as a promising alternative treatment for localized infections. 10, 14, 15 APDI involves the direct application of the PS to the infected tissue rather than being injected intravenously, as is usual with PDT for cancer.
A frequently employed class of antimicrobial PSs are the blue dyes known as phenothiazinium salts, including toluidine blue O (TBO), 7 methylene blue (MB) 9 and azure dyes. 16 Phenothiazinium salts are amphipathic tricyclic planar molecules that possess one intrinsic quaternary nitrogen atom and have phototoxic efficiency against a broad range of microorganisms, 17, 18 including Escherichia coli,
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Staphylococcus aureus, 18 streptococci, 19 Listeria monocytogenes, 20 Vibrio vulnificus 21 and Candida albicans. 9, 22 At the present time, the only PSs used clinically for antimicrobial treatments are phenothiazinium salts. For instance, the combination of MB or TBO together with red light is used to disinfect blood products, sterilize dental cavities and root canals, and for the treatment of periodontitis. 23 APDI has been shown to have a microbicidal effect against a broad range of pathogens. 15,22,24 -28 It is well known that there is a fundamental difference in susceptibility between Gram-positive bacteria, Gram-negative bacteria and fungi due to physiological differences in the cell walls in these classes of microorganisms.
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In addition, different members of the same class of microbes seem to have different susceptibility patterns to APDI due to intrinsic metabolic determinants (enzymatic defence against reactive oxygen species and efflux pumps that recognize PS molecules).
It has been suggested that amphipathic cations represent the existing natural substrates of microbial efflux pumps (MEPs), 29 and it has been established that disabling MEPs by employing either efflux mutants or synthetic efflux pump inhibitors (EPIs) leads to a striking increase in the activity of a wide array of plant secondary metabolites, including natural efflux substrates. 30 We previously showed that phenothiazinium salts, which are structurally characterized as amphipathic cations, are substrates of efflux systems in Gram-positive and Gramnegative bacteria. 31 These observations led to a study that demonstrated that specific EPIs could potentiate APDI in bacteria. 31 The main aim of this study was to investigate whether the major fungal efflux systems (MFSs and ABCs) affect the efficiency of MB-mediated APDI in pathogenic fungi. We report that both MESs in C. albicans do affect the efficiency of APDI using MB and red light, and that the fungicidal effect of MB APDI can be potentiated by the ABC inhibitor verapamil, but not by the MFS inhibitor INF 271 .
Materials and methods

Microbial strains
The C. albicans strains used in this study are listed in Table 1 . 32 -39 C. albicans DAY185 is not an azole-resistant strain, similar to YEM12. However, the resistance of strains YEM13, 14 and 15 to azoles is higher (64 -128×MIC) than YEM12 and DAY185. 33, 39 Cells were grown by shaking in yeast extract/peptone/dextrose (YPD) liquid medium at 308C and cell density was assessed with a spectrophotometer (Mini 1240, Shimadzu, Columbia, MD, USA) at 600 nm (OD 600 ).
Incubation with compounds
Yeast suspensions in PBS (initial concentration 10 7 cfu/mL) were incubated with the appropriate pump inhibitors for 30 min and then the cells were centrifuged at 4000 g and washed twice in PBS. Verapamil (+) (Sigma-Aldrich, St Louis, MO, USA) was designated as an EPI for ABCs, and INF 271 (Chembridge, San Diego, CA, USA) has been extensively used to block MFSs mostly in Gram-positive bacteria. 7, 40, 41 Stock solutions were prepared in DMSO (INF 271 ) or ethanol (verapamil) at a concentration of 10 mg/mL and stored at 2208C. The inhibitors were incubated with yeast cells at final concentrations of 10, 25 and 50 mg/mL. Subsequently the washed cells were incubated with PS for another 30 min, then centrifuged (as described earlier), washed twice and resuspended in sterile PBS. A stock solution of MB (Sigma-Aldrich) was prepared in distilled water at a concentration of 10 mM, filtered through a sterile 0.22 mm filter membrane and stored for a maximum of 2 weeks at 48C in the dark before use. In some cases the yeast cells were incubated with PS alone, without inhibitors.
APDI studies
The yeast suspensions were placed in 96-well microtitre plates (Fisher Scientific, Pittsburgh, PA, USA) and illuminated using a GaAlAs diode laser (Photon Lase III, DMC, Sã o Carlos, Brazil) with a wavelength of 660 nm and a total power of 50 mW. Yeast strains were continually irradiated from the top of the flat-bottom microtitre plate with fluences ranging from 0 to 60 J/cm 2 at a fluence rate of 165 mW/cm 2 . During illumination, aliquots of 20 mL were taken to determine the cfus. The contents of the wells were constantly stirred during illumination (to ensure that yeast cells did not settle to the bottom of the wells) and were mixed before sampling. The aliquots were serially diluted 10-fold in PBS to give dilutions of 10 21 to 10 25 times the original concentrations and were streaked horizontally on square YPD agar plates as described by Jett et al. 42 This allowed a maximum of 7 logs of killing to be measured. Plates were incubated at 378C overnight. Two types of control conditions were used: illumination in the absence of PS and incubation with PS in the dark.
PS uptake
C. albicans cells were incubated with EPI as previously described and then rhodamine 123 (R123; Eastman Kodak, Rochester, NY, USA), a mitochondrial localizing dye, 43 and MB were added into sample tubes at a final concentration of 10 mM and 100 mM, respectively. Suspensions were incubated at room temperature for 30 min, washed twice and fixed in 2% formaldehyde and 10% glycerol. Aliquots of 4 mL were taken from the pellet, placed on a slide and covered with a cover slip for analysis. A confocal Prates et al.
laser microscope (Leica TCS NT, Leica Mikroskopie und System GmBH, Wetzlar, Germany) with excitation at 488 nm from an argon laser was used. The cells were observed with an ×100 oil immersion objective and images at 512×512 pixels resolution were recorded with a dimension of 0.13 mm on each side of one pixel. Two channels collected fluorescence signals in either the green range (580 nm dichroic mirror plus 525/50 nm bandpass filter) from R123 or in the red range (580 nm dichroic mirror plus 665 nm longpass filter) from MB. The false output colour green and red images were superimposed for the figures. The images were analysed by counting the red pixels for cells in the fields (related to MB fluorescence). The cells were analysed individually using image processing software (ImageJ 1.41o, National Institutes of Health, Bethesda, MD, USA) and red, green, blue (RGB) data were measured in the selected fields.
Statistics
Values are means from three separate experiments and bars are standard deviations (SDs). Statistical analysis of the cfu data was performed using one-way analysis of variance (ANOVA). Mean comparisons were carried out with Tukey's test with a significance level at 5% (P,0.05). 44 Differences between RGB data means were compared using a t-test with the overall significance level set at 5%.
Results
The survival fraction of C. albicans strains treated only with laser irradiation or with MB alone did not show a significant difference compared with the control cells in all experiments (data not shown). There were substantial differences in the killing effect and dye uptake after MB-mediated APDI. Due to the effluxspecific characteristics of each strain and the experimental methodology adopted, the data will be presented in different sections.
Impact of MFS efflux systems in MB-mediated APDI
In order to test this hypothesis we employed an isogenic pair of C. albicans strains: the YEM13-overexpressing MFS system and the parent YEM12. Incubation with 100 mm MB and subsequent APDI revealed identical phototoxicity between both strains up to 40 J/cm 2 ( Figure 1a ). An increase in fluence (60 J/cm 2 ) led to a statistically significant reduction of 3 logs in C. albicans YEM12 whereas YEM13 exhibited only 1.5 logs of inactivation. This observation indicates that MFS system overexpression contributed slightly to a protective effect of MB APDI phototoxicity in yeast cells after 6 min of irradiation.
Impact of the ABC systems in MB-mediated APDI
We tested this hypothesis by comparing APDI with MB for two isogenic C. albicans strains: the parent YEM14 and the YEM15 mutant overexpressing CDR1/CDR2. The effect of ABC overexpression was more prominent when compared with MFS overexpression in protecting against MB-mediated APDI. YEM15 was resistant to APDI killing (no killing after 6 min irradiation, 60 J/cm 2 with 100 mM MB) whereas YEM14 showed a fluence-dependent killing, leading to 5 logs of killing (P ¼0.008) under the same APDI conditions (Figure 1b) . These experiments showed that ABC transporter overexpression effectively abolished the effect of MB-mediated APDI on C. albicans.
Effect of EPIs in MB-mediated APDI
Since efflux systems affect APDI of MB in C. albicans, a logical strategy was to explore whether EPIs could potentiate APDI with MB. We used two well-documented EPIs (one for each corresponding efflux system), INF 271 (targeting MFS) and verapamil (+) (known to target ABCs both in yeast and mammalian systems), and used the wild-type reference C. albicans strain DAY185. APDI with MB did not show any significant phototoxicity at 20 J/cm 2 , but killing increased in a dose-response manner, reaching 2 logs after 6 min of irradiation (60 J/cm 2 ). Preexposure to INF 271 followed by MB-mediated PDI, resulted in a paradoxical protection rather than enhancement of phototoxicity (Figure 2) .
On the other hand pre-exposure of DAY185 cells to verapamil (+) and subsequent MB-mediated APDI led to a moderate increase in phototoxicity when compared with the PDI efficacy of MB in the absence of EPIs (1 log, 60 J/cm 2 , P ¼ 0.00053; Figure 2 ).
In addition, pre-exposure of the CDR1/CDR2-overexpressing mutant YEM15 in verapamil (+) and subsequent APDI revealed 2 logs of cell reduction in the presence of the EPI at 60 J/cm 2 , compared with virtually no effect in the absence of the ABC pump inhibitor (Figure 3) . However, the increase in verapamil 
Effect of efflux systems on PS uptake
We employed the same isogenic pairs used in the APDI studies-MB and R123 (a designated tracker for mitochondria that is also a substrate of yeast efflux systems)-and confocal laser scanning microscopy (CLSM). Images obtained from the isogenic pair YEM12/YEM13 showed intense red and green fluorescence, indicating the localization of both MB and R123 in the yeast cell (Figure 4 ). MB accumulation in cytoplasm and nucleus were observed in both strains by the superimposition of green and red fluorescence images. MB did not appear to accumulate in the mitochondria. Comparing the red intensity of the strains, C. albicans YEM12 presented a slight difference compared with YEM13, seen as a more intense red image, suggesting a higher concentration of MB in YEM12. On the other hand, a remarkable difference was observed between CLSM images for accumulation of MB/R123 in the pair YEM14/YEM15 (Figure 4) . C. albicans YEM14 showed both red and green fluorescence whereas no detectable MB or R123 fluorescence was observed in YEM15. Furthermore, we employed the CLSM images to determine cellular uptake by the quantification of MB fluorescence (red pixels) ( Figure 5 ). The concentration of intracellular MB was significantly reduced in both mutant strains YEM13 and YEM15 compared with the wild-type strains. However, ABC overexpression promoted an 90% (P,0.001) reduction in the intracellular concentration of MB whereas a 40% (P,0.01) reduction was observed for the MFS-overexpressing strain. This finding supported further the primary observation from the APDI studies that MB efflux is predominantly affected by the ABC efflux systems in C. albicans.
EPIs and MB uptake in C. albicans DAY185
Using CLSM and the pair of EPIs employed in the APDI studies, we assessed differences in accumulation for both MB and R123 in C. albicans DAY185. Incubation with EPIs was performed as described in the Materials and methods section and applied in the APDI experiments. C. albicans DAY185 pre-exposure to verapamil (+) or single incubation with MB and R123 showed intense red and green fluorescence ( Figure 6 ). Superimposed images of MB and R123 fluorescence show MB uptake in mitochondria in the presence or absence of verapamil (+). On the other hand, INF 271 pre-exposure reduced the intracellular fluorescence intensity of MB. In addition, quantification of MB fluorescence (red pixels) in CLSM images showed that pre-incubation with each EPI had different effects on MB uptake (Figure 7 ). The verapamil (+) inhibition of ABC pumps increased the amount of intracellular MB by 50% (P,0.01); however, INF 271 reduced MB uptake by 70% (P,0.0001).
Discussion
There have been a substantial number of published APDI studies that target pathogenic fungi employing an array of PSs, including phenothiazinium salts (MB and TBO), under a range of conditions. 8,9,23,45 -47 Nevertheless, in the case of C. albicans there is minimal information implicating phenotypic cell physiology determinants concerning the uptake and localization of MB as well as information on the APDI mechanism. Giroldo et al. 48 suggested that MB-mediated APDI may be related to damage to the plasma membranes. The present study demonstrated a role of the predominant yeast MESs (MFSs and ABCs) in both MB uptake and phototoxicity towards C. albicans. As we have previously reported, MB is a substrate for bacterial efflux systems and the use of specific EPIs enhances its phototoxicity.
7,40 MB behaves as a substrate of the phylogenetically distant yeast efflux systems, and these can dramatically alter MB APDI efficacy. Overexpression of both systems reduced MB uptake, as well as the killing effect of MB-mediated APDI, suggesting that MFSs and ABCs are involved in MB export. Moreover, the protective effect of the MFS system in APDI killing was less pronounced than ABCs, and it was observed only after several minutes of irradiation. Since the particular MFS system in Prates et al.
C. albicans MDR1 is a proton antiporter and substrate transport is dependent on chemiosmotic ion gradients, 6 both MB concentrations inside and outside the cell are important in this process. In the present study, the excess of MB was washed out and the cells were resuspended in PBS before irradiation. Incorporating a wash step before illumination has been shown to dramatically reduce the APDI effect of TBO in C. albicans. 49 Thus, the absence of MB outside the cells probably induced a slow efflux of MB through the MFS system, providing a plausible explanation for the relation of MB APDI efficacy and MFS overexpression. On the other hand, evidence of the effect of ABC on MB efflux is compelling, considering both the extremely low uptake and the protection from APDI in the ABC-overexpressing mutant.
Distinct killing effects were observed for wild-type strains DAY185, YEM12 and YEM14 under the same MB concentration and irradiation parameters. In addition, C. albicans DAY185 and YEM12 are more susceptible to azole (MIC 0.5 mg/L and 1 mg/L, respectively) than YEM14 (MIC 64 mg/L). 33, 39 In contrast, the MB APDI killing was greater for YEM14 compared with the other wild-type strains. Although the azole resistance is also related to efflux pump expression, 5 the MB APDI effect is dependent on other phenotypic determinants related to oxidative stress responses (expression of enzymes that detoxify reactive oxygen species and production of scavengers). One possible explanation for the differences in MB APDI effect may be the variation in response to oxidative stress among MB PDI of Candida is influenced by multidrug efflux systems 1529 JAC several C. albicans strains, resulting in different susceptibility patterns to oxidant agents. 50 Although each strain can be inactivated under a different set of parameters, we used a sub-lethal dose of APDI to accentuate the differences between parent strains.
Cells were washed after incubation with both EPIs based on our previous observations that pre-incubation with EPIs and subsequent washing enhances antimicrobial PDI. 7 It is quite possible that this phenomenon is either species-or EPI-specific, and there is no direct mechanistic evidence regarding whether EPI washing prevents or promotes potential interaction between EPIs and PSs. Regarding the direct antimicrobial effect of both EPIs, there is extensive published information for INF 271 in Grampositive bacteria and non-pathogenic yeasts. 30, 51 Moreover, verapamil is routinely used worldwide in yeast susceptibility testing as well as rhodamine uptake and efflux experiments with a variety of C. albicans phenotypes at the same or higher concentrations (50 -100 mM) without any toxic effect. 52 The results of both MB APDI and uptake in DAY185 employing two EPIs (INF 271 and verapamil) that have reported activity in each efflux system further supported the initial observations with the efflux-overexpressing phenotypes. Verapamil increased the amount of intracellular MB and improved APDI efficiency. The INF 271 contribution was rather puzzling, as it essentially dramatically reduced MB uptake and phototoxicity in DAY185 Prates et al. We observed that DAY185 pre-treated with INF 271 was not killed and MB uptake was reduced. MFS pump families are reported to be responsible for the uptake and export of several substances in C. albicans. 6 The low overall effect of MFS overexpression could be explained if MFS was responsible for both uptake and efflux of MB and the effects of increasing MFS levels effectively cancelled each other out.
Antifungal therapy is a challenging problem in the management of infections caused by clinically relevant fungal pathogens because of the high incidence of resistance developed during therapy, especially in immunocompromised individuals. 5 The use of EPIs has been proposed as a viable combination with antimicrobials in a wide variety of pathogenic efflux systems, including those primary suspects in C. albicans. 4, 7, 30, 40 The current study demonstrates that designated ABC EPIs (verapamil) substantially potentiated APDI with MB, even against a C. albicans strain overexpressing CDR1/CDR2. Our results also suggest that EPIs may provide a viable and promising combination with antifungal chemotherapy. This pump inhibitor was reported to strongly reduce the MICs for fluconazole and itraconazole resistance of an azole-resistant strain. 53 It is proposed that antifungal resistance can be reversed by an ABC pump-dependent mechanism. 4 In conclusion, our results demonstrated that the influx as well as the efflux of MB is regulated by MFS systems and blocking this gate before incubation with MB can decrease the uptake and APDI effects. On the other hand, ABC pumps are directly implicated in MB efflux from the cell cytoplasm. 
